Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies.
View / Open Files
Authors
Donaghy, Paul C
McKiernan, Elizabeth
Firbank, Michael J
Lloyd, Jim
Petrides, George S
Thomas, Alan J
O'Brien, John T
Publication Date
2019-01Journal Title
Neurobiol Aging
ISSN
0197-4580
Publisher
Elsevier BV
Volume
73
Pages
74-81
Language
eng
Type
Article
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Mak, E., Donaghy, P. C., McKiernan, E., Firbank, M. J., Lloyd, J., Petrides, G. S., Thomas, A. J., & et al. (2019). Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies.. Neurobiol Aging, 73 74-81. https://doi.org/10.1016/j.neurobiolaging.2018.09.004
Abstract
Although dementia with Lewy bodies (DLB) is a synucleinopathy, it is frequently accompanied by beta amyloid (Aβ) accumulation. Elucidating the relationships of Aβ with gray matter atrophy in DLB may yield insights regarding the contributions of comorbid Alzheimer's disease to its disease progression. Twenty healthy controls and 25 DLB subjects underwent clinical assessment, [18F]-Florbetapir, and 3T magnetic resonance imaging. FreeSurfer was used to estimate cortical thickness and subcortical volumes, and PetSurfer was used to quantify [18F]-Florbetapir standardized uptake value ratio. Principal component analysis was used to identify the dominant Aβ component for correlations with regional cortical thickness, hippocampal subfields, and subcortical structures. Relative to healthy controls, the DLB group demonstrated increased Aβ in widespread regions encompassing the frontal and temporoparietal cortices, whereas cortical thinning was restricted to the temporal lobe. Among DLB subjects, the Aβ component was significantly associated with more severe hippocampal and subiculum atrophy. These findings may reflect an early process of superimposed AD-like atrophy in DLB, thereby conferring support for the therapeutic potential of anti-Aβ interventions in people with DLB.
Keywords
Alzheimer's disease, Amyloid, Dementia with Lewy bodies, MRI, PET, Aged, Aged, 80 and over, Alzheimer Disease, Amyloid beta-Peptides, Atrophy, Disease Progression, Female, Hippocampus, Humans, Lewy Body Disease, Magnetic Resonance Imaging, Male, Middle Aged, Positron-Emission Tomography
Sponsorship
NIHR Newcastle Biomedical Research Centre; Eli Lilly and Company
Identifiers
External DOI: https://doi.org/10.1016/j.neurobiolaging.2018.09.004
This record's URL: https://www.repository.cam.ac.uk/handle/1810/286205
Rights
Licence:
http://www.rioxx.net/licenses/all-rights-reserved
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk